BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

Dendritic cell (DC) vaccines show promising effects in cancer immunotherapy. However, their efficacy is affected by a number of factors, including (1) the quality of the DC vaccine and (2) tumor immune evasion. The recently characterized BDCA1+CD14+ immunosuppressive cells combine both aspects; thei...

Full description

Bibliographic Details
Main Authors: Thomas J. van Ee, Heleen H. Van Acker, Tom G. van Oorschot, Viggo F. Van Tendeloo, Evelien L. Smits, Ghaith Bakdash, Gerty Schreibelt, I. Jolanda M. de Vries
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Vaccines
Subjects:
BDCA1+CD14+ cells
cancer
dendritic cells
cancer immunotherapy
immune suppression
tumor microenvironment
Online Access:http://www.mdpi.com/2076-393X/6/3/65

Internet

http://www.mdpi.com/2076-393X/6/3/65

Similar Items